Objective: To assess the predictive factors at 12 month and 10 year adherence to Continuous Positive Airway Pressure (CPAP) in patients with Obstructive Sleep Apnoea (OSA).
Methods: Retrospective data analysis of patients starting CPAP between 2006 and 2009. After 12 months (T1) from start and during a 10 year follow up the following data were recorded: Body Mass Index (BMI), Time of night use, Epworth Sleepiness Scale (ESS) score.
Background: The nightly use of continuous positive airway pressure (CPAP) increases the quality of life of patients affected by obstructive sleep apnea syndrome (OSAS). The aim of this study was to develop and validate a questionnaire to assess the psychological and physical impact of OSAS and adherence to the CPAP device.
Methods: Ninety-six patients underwent a polygraphic examination to establish a diagnosis of OSAS.
J Cardiovasc Med (Hagerstown)
November 2006
Background: There is little evidence available about the relationship between metabolic syndrome as a comprehensive clinical entity and obstructive sleep apnea (OSA) with respect to the cardiovascular risk of patients with coexisting metabolic syndrome and OSA.
Methods: Eighty-nine consecutive patients (males 85%, aged 62 +/- 11 years) with newly-diagnosed OSA were evaluated for the presence of metabolic syndrome and the incidence of cardiovascular events after implementation of continuous positive airway pressure (CPAP) therapy was registered during medium-term follow-up. The diagnosis of OSA and metabolic syndrome was obtained by overnight polygraphy [with a presence of an apnea-hypopnea index (AHI) >or= 15] and following NCEP ATP III recommendations, respectively.